Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01309308
Other study ID # KA 09/248
Secondary ID
Status Completed
Phase N/A
First received March 4, 2011
Last updated October 3, 2011
Start date February 2011
Est. completion date March 2011

Study information

Verified date October 2011
Source Baskent University
Contact n/a
Is FDA regulated No
Health authority Turkey: Ethics Committee
Study type Interventional

Clinical Trial Summary

Sweeping the membranes in term pregnancy may shorten the cervix and reduce the time to delivery.


Description:

Cervical length will be measured in both groups. The membranes will be swept in pregnancies beyond 38 weeks by digital examination in the study group. The control group will only be examined for Bishop score. Two days later cervical length will be Measured once more.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date March 2011
Est. primary completion date March 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 42 Years
Eligibility Inclusion Criteria:

- The patients who completed the 38th week of pregnancy, otherwise healthy gravida who have no contraindication to vaginal delivery.

Exclusion Criteria:

- Women who have chronic disease complicating pregnancy, multiple pregnancies and in whom vaginal delivery is contraindicated.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Disorder of Amniotic Cavity and/or Membrane

Intervention

Procedure:
sweeping the membranes
The cervical length will be measured and the patient will be examined to determine the Bishop score. Later the the membranes will be swept.
Other:
No sweeping group
Cervical length will be measured by transvaginal USG and the patient will be examined to determine the Bishop score.

Locations

Country Name City State
Turkey Baskent Universitesi Seyhan Arastirma ve Uygulama Hastanesi Adana

Sponsors (2)

Lead Sponsor Collaborator
Huriye Ayse Parlakgumus Baskent University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cervical Shortening Cervix 1 was measured at the sagittal plane of cervix from external to the internal os. Two days later cervix 2 was measured the same way. The cervical shortening was calculated from subtracting cervix 1 from cervix 2. 2days No
Secondary The Duration of Latency Until Labor The period (in days) from the last cervical measurement to the start of second phase of labor. 15 days No
See also
  Status Clinical Trial Phase
Recruiting NCT02111148 - Vaginal Fluid Wash in Pre-labour Rupture of Membranes N/A